Biology Reference
In-Depth Information
Ayyavoo V, Mahboubi A, Mahalingam S, Ramalingam R, Kudchodkar S, Williams WV, Green
DR, Weiner DB. 1997. HIV-1 Vpr suppresses immune activation and apoptosis through regu-
lation of nuclear factor kappa B [see comments]. Nat Med 3: 1117±1123.
Baier M, Kurth R. 1997. Fighting HIV-1 with IL-16 [news; comment]. Nat Med 3: 605±606.
Baier M, Werner A, Bannert N, Metzner K, Kurth R. 1995. HIV suppression by interleukin-16
[letter; comment] [see comments]. Nature 378: 563.
Benjamin D, Sharma V, Knobloch TJ, Armitage RJ, Dayton MA, Goodwin RG. 1994. B cell IL-7.
Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. J Immunol 152: 4749±
4757.
Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, Bressler P, Orenstein JM,
Fauci AS. 1992. Interferon gamma induces the expression of human immunode®ciency virus in
persistently infected promonocytic cells (U1) and redirects the production of virions to intracyto-
plasmic vacuoles in phorbol myristate acetate-di¨erentiated U1 cells. J Exp Med 176: 739±750.
Bovolenta C, Testolin L, Benussi L, Lievens PM, Liboi E. 1998. Positive selection of apoptosis-
resistant cells correlates with activation of dominant-negative STAT5. J Biol Chem 273: 20779±
20784.
Bovolenta C, Camorali L, Lorini AL, Ghezzi S, Vicenzi E, Lazzarin A, Poli G. 1999a. Constitutive
activation of STATs upon In vivo human immunode®ciency virus infection [In Process Cita-
tion]. Blood 94: 4202±4209.
Bovolenta C, Camorali L, Lorini AL, Vallanti G, Ghezzi S, Tambussi G, Lazzarin A, Poli
G. 1999b. In vivo administration of recombinant IL-2 to individuals infected by HIV down-
modulates the binding and expression of the transcription factors ying-yang-1 and leader bind-
ing protein-1/Late simian virus 40 factor. J Immunol 163: 6892±6897.
Bovolenta C, Lorini AL, Mantelli B, Camorali L, Novelli F, Biswas P, Poli G. 1999c. A selective
defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937
clones prevents the antiretroviral e¨ect of IFN-gamma against HIV-1. J Immunol 162: 323±330.
Briant L, Reynes J, Coudronniere N, Benezech JP, Devaux C. 1999. HIV-1 reactivation in resting
peripheral blood mononuclear cells of infected adults upon in vitro CD4 cross-linking by ligands
of the CDR2-loop in extracellular domain 1. J Acquir Immune De®c Syndr 21: 9±19.
Buonaguro L, Buonaguro FM, Giraldo G, Ensoli B. 1994. The human immunode®ciency virus type
1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like
structure. J Virol 68: 2677±2682.
Chapuis AG, Paolo Rizzardi G, D'Agostino C, Attinger A, Knabenhans C, Fleury S, Acha-Orbea
H, Pantaleo G. 2000. E¨ects of mycophenolic acid on human immunode®ciency virus infection
in vitro and in vivo [see comments]. Nat Med 6: 762±768.
Chun TW, Engel D, Mizell SB, Ehler LA, Fauci AS. 1998. Induction of HIV-1 replication in
latently infected CD4
T cells using a combination of cytokines. J Exp Med 188: 83±91.
Cicala C, Arthos J, Rubbert A, Selig S, Wildt K, Cohen OJ, Fauci AS. 2000. HIV-1 envelope in-
duces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4()
T cells. Proc Natl Acad Sci USA 97: 1178±1183.
Clerici M, Shearer GM. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol
Today 15: 575±581.
Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identi®cation of
RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by
CD8
T cells [see comments]. Science 270: 1811±1815.
Collette Y, Dutartre H, Benziane A, Ramos M, Benarous R, Harris M, Olive D. 1996. Physical and
functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J Biol Chem
271: 6333±6341.
Collette Y, Dutartre H, Benziane A, Olive D. 1997. The role of HIV1 Nef in T-cell activation: Nef
impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck. Res
Virol 148: 52±58.
